4-carbazol-9-yl-8-(4,6-diphenyl-1,3,5-triazin-2-yl)-2-phenyl-[1]benzothiolo[3,2-d]pyrimidine
C43H26N6S — CID 139551093
Data last refreshed: (MolForge compound catalog, from PubChem)
About 4-carbazol-9-yl-8-(4,6-diphenyl-1,3,5-triazin-2-yl)-2-phenyl-[1]benzothiolo[3,2-d]pyrimidine
4-carbazol-9-yl-8-(4,6-diphenyl-1,3,5-triazin-2-yl)-2-phenyl-[1]benzothiolo[3,2-d]pyrimidine (PubChem CID 139551093) has the molecular formula C43H26N6S and a molecular weight of 658.79 g/mol. Its IUPAC name is 4-carbazol-9-yl-8-(4,6-diphenyl-1,3,5-triazin-2-yl)-2-phenyl-[1]benzothiolo[3,2-d]pyrimidine.
Molecular Properties
| Compound Name | 4-carbazol-9-yl-8-(4,6-diphenyl-1,3,5-triazin-2-yl)-2-phenyl-[1]benzothiolo[3,2-d]pyrimidine |
|---|---|
| PubChem CID | 139551093 |
| Molecular Formula | C43H26N6S |
| Molecular Weight | 658.79 g/mol |
| Exact Mass | 658.19 |
| IUPAC Name | 4-carbazol-9-yl-8-(4,6-diphenyl-1,3,5-triazin-2-yl)-2-phenyl-[1]benzothiolo[3,2-d]pyrimidine |
| SMILES | c1ccc(-c2nc(-c3ccccc3)nc(-c3ccc4sc5c(-n6c7ccccc7c7ccccc76)nc(-c6ccccc6)nc5c4c3)n2)cc1 |
| InChI | InChI=1S/C43H26N6S/c1-4-14-27(15-5-1)39-44-37-33-26-30(42-46-40(28-16-6-2-7-17-28)45-41(47-42)29-18-8-3-9-19-29)24-25-36(33)50-38(37)43(48-39)49-34-22-12-10-20-31(34)32-21-11-13-23-35(32)49/h1-26H |
| InChIKey | UGCMGZRKXUDKOX-UHFFFAOYSA-N |
| XLogP | 10.79 |
| TPSA | 69.38 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 50 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 658.79 |
| LogP ≤ 5 | 10.79 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 7 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 139551093 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.